Authors: GELFAND MM FUGERE P BISSONNETTE F WITTA B YANG HM LORRAIN J FERENCZY A

Citation: Mm. Gelfand et al., CONJUGATED ESTROGENS COMBINED WITH SEQUENTIAL DYDROGESTERONE OR MEDROXYPROGESTERONE ACETATE IN POSTMENOPAUSAL WOMEN - EFFECTS ON LIPOPROTEINS, GLUCOSE-TOLERANCE, ENDOMETRIAL HISTOLOGY, AND BLEEDING, Menopause, 4(1), 1997, pp. 10-18

Authors: BISSONNETTE F LUSSIERCACAN S FUGERE P BERUBE S

Citation: F. Bissonnette et al., METABOLIC EFFECT OF 2 HORMONAL PREPARATIONS IN POSTMENOPAUSAL WOMEN, Maturitas, 27(3), 1997, pp. 275-284

Authors: GELFAND M FUGERE P BISSONNETTE F

Citation: M. Gelfand et al., CARDIOVASCULAR RISK-FACTORS DURING SEQUENTIALLY COMBINED 17-BETA ESTRADIOL AND DYDROGESTERONE (FEMOSTON(R)) - RESULTS FROM A ONE-YEAR STUDYIN POSTMENOPAUSAL WOMEN, Maturitas, 26(2), 1997, pp. 125-132

Authors: CHATEL A FUGERE P BISSONNETTE F BERUBE S

Citation: A. Chatel et al., PSYCHOLOGICAL DISTRESS AND SEXUALITY IN A GROUP OF WOMEN ATTENDING A MENOPAUSE CLINIC - EFFECT OF HORMONAL REPLACEMENT THERAPY, Menopause, 3(3), 1996, pp. 165-171

Authors: FAUGHNAN M LEPAGE R FUGERE P BISSONNETTE F BROSSARD JH DAMOUR P

Citation: M. Faughnan et al., SCREENING FOR THYROID-DISEASE AT THE MENOPAUSAL CLINIC, Clinical and investigative medicine, 18(1), 1995, pp. 11-18

Authors: ROSS AH BOYD ME COLGAN TJ FERENCZY A FUGERE P LORRAIN J

Citation: Ah. Ross et al., COMPARISON OF TRANSDERMAL AND ORAL SEQUENTIAL GESTAGEN IN COMBINATIONWITH TRANSDERMAL ESTRADIOL - EFFECTS ON BLEEDING PATTERNS AND ENDOMETRIAL HISTOLOGY, Obstetrics and gynecology, 82(5), 1993, pp. 773-779